Y. Tsubakihara

发表

2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

K. Iseki, S. Nakai, H. Hirakata, 2010, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study

S. Fukuhara, M. Iwasaki, S. Morita, 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Prospective Randomized Study Evaluating the Efficacy of the Spherical Adsorptive Carbon AST-120 in Chronic Kidney Disease Patients with Moderate Decrease in Renal Function

E. Imai, Y. Fukuhara, T. Shoji, 2006, Nephron Clinical Practice.

[Circadian blood pressure pattern in the patients with chronic glomerulonephritis].

T. Shoji, Y. Tsubakihara, N. Okada, 1993, Nihon Jinzo Gakkai shi.

Are glomerular lesions alternatives to microalbuminuria in predicting later progression of diabetic nephropathy?

T. Shoji, Y. Tsubakihara, N. Okada, 1996, Clinical nephrology.

The relationship between dialysis prescription/dialysis dose and patient mortality

K. Iseki, S. Nakai, Kazuyuki Suzuki, 2011 .

Serum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients

T. Hasegawa, K. Iseki, Akihiko Kato, 2016, PloS one.

Urinary Type IV Collagen in Nondiabetic Kidney Disease

H. Rakugi, Y. Isaka, E. Imai, 2010, Nephron Clinical Practice.

Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney disease.

H. Rakugi, Y. Isaka, T. Shoji, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial

M. Nangaku, T. Akizawa, T. Hamano, 2021, American Journal of Nephrology.

Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan

M. Iwasaki, M. Nangaku, I. Narita, 2020, Clinical and Experimental Nephrology.

A 24‐Week Anemia Correction Study of Daprodustat in Japanese Dialysis Patients

M. Nangaku, T. Akizawa, Taeko Yonekawa, 2020, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan

Tetsuhiro Tanaka, M. Nangaku, T. Akizawa, 2018, Clinical and Experimental Nephrology.

Association between responsiveness to methoxy polyethylene glycol‐epoetin beta and renal survival in patients with non‐dialysis‐dependent chronic kidney disease: A pooled analysis of individual patient‐level data from clinical trials

Y. Ohashi, H. Hirakata, T. Kitazono, 2017, Nephrology.

Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects

M. Nangaku, T. Kohno, T. Akizawa, 2016, American Journal of Nephrology.

Thresholds of iron markers for iron deficiency erythropoiesis—finding of the Japanese nationwide dialysis registry

K. Iseki, N. Fujii, Hiroyasu Yamamoto, 2015, Kidney international supplements.

High Hemoglobin Levels Maintained by an Erythropoiesis‐Stimulating Agent Improve Renal Survival in Patients with Severe Renal Impairment

M. Iwasaki, T. Akizawa, Y. Tsubakihara, 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Low Hemoglobin Levels and Hypo‐Responsiveness to Erythropoiesis‐Stimulating Agent Associated With Poor Survival in Incident Japanese Hemodialysis Patients

Y. Ohashi, Y. Tomino, H. Hirakata, 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Effect of anemia correction to the modestly high hemoglobin level in patients with chronic kidney disease on left ventricular hypertrophy

M. Hiroe, M. Akaishi, T. Akizawa, 2013 .

High Target Hemoglobin With Erythropoiesis‐Stimulating Agents Has Advantages in the Renal Function of Non‐Dialysis Chronic Kidney Disease Patients

H. Hirakata, T. Akiba, T. Akizawa, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

To Treat or Not To Treat Renal Anemia of Chronic Kidney Disease Patients?

Y. Tsubakihara, 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan.

E. Imai, T. Hamano, Takahito Ito, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Different impact of hemodialysis vintage on cause-specific mortality in long-term hemodialysis patients.

K. Iseki, K. Yamagata, Y. Tsubakihara, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effects of Sustained‐Release Beraprost in Patients With Primary Glomerular Disease or Nephrosclerosis: CASSIOPEIR Study Results

Jianghua Chen, H. Chen, T. Fujita, 2020, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3

A. Nishiyama, N. Fujii, H. Rakugi, 2012, Laboratory Investigation.

Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis-stimulating agents

H. Rakugi, Y. Isaka, Terumasa Hayashi, 2013, Clinical and Experimental Nephrology.

Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study

K. Iseki, N. Hanafusa, A. Fukatsu, 2014, PloS one.

Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients.

K. Iseki, T. Shoji, Y. Tsubakihara, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Hypomagnesemia in Type 2 Diabetic Nephropathy

H. Rakugi, Y. Isaka, T. Shoji, 2012, Diabetes Care.

Hypomagnesemia in Type 2 Diabetic Nephropathy

H. Rakugi, Y. Isaka, T. Shoji, 2012, Diabetes Care.

Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy.

M. Hori, M. Togawa, E. Imai, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Japanese Society for Dialysis Therapy Clinical Guideline for “Hemodialysis Initiation for Maintenance Hemodialysis”

K. Iseki, J. Minakuchi, H. Hirakata, 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Cigarette smoking and progression of IgA nephropathy.

H. Rakugi, Y. Isaka, M. Horio, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Late Dialysis Start Did Not Affect Long‐Term Outcome in Japanese Dialysis Patients: Long‐Term Prognosis From Japanese Society of Dialysis Therapy Registry

K. Iseki, S. Nakai, K. Yamagata, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Ideal Timing and Predialysis Nephrology Care Duration for Dialysis Initiation: From Analysis of Japanese Dialysis Initiation Survey

Adenosine A1 receptor antagonist improves intradialytic hypotension.

M. Hori, E. Imai, Y. Tsubakihara, 2006, Kidney international.

A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN).

H. Rakugi, Y. Isaka, E. Imai, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2007)

T. Hasegawa, K. Wakai, K. Iseki, 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2012)

T. Hasegawa, K. Wakai, K. Iseki, 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2009)

T. Hasegawa, K. Wakai, K. Iseki, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008)

T. Hasegawa, K. Wakai, K. Iseki, 2010, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Overview of Regular Dialysis Treatment in Japan as of 31 December 2006

K. Wakai, K. Iseki, S. Nakai, 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2005)

K. Wakai, K. Iseki, S. Nakai, 2007, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathy

H. Rakugi, Y. Isaka, E. Imai, 2015, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Higher Survival Rates of Chronic Hemodialysis Patients on Anti-Hypertensive Drugs

K. Iseki, S. Nakai, T. Akiba, 2009, Nephron Clinical Practice.

Effects of anemia correction by erythropoiesis-stimulating agents on cardiovascular function in non-dialysis patients with chronic kidney disease.

K. Aonuma, M. Hiroe, M. Akaishi, 2012, International heart journal.

Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy

H. Rakugi, Y. Isaka, E. Imai, 2012, Clinical and Experimental Nephrology.

Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients.

K. Iseki, Kazuyuki Suzuki, T. Yamakawa, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Original Investigation Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients

K. Iseki, Kazuyuki Suzuki, T. Yamakawa, 2015 .

Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder

K. Iseki, N. Fujii, T. Shigematsu, 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.

N. Fujii, H. Rakugi, S. Mikami, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Factors associated with the incidence of dialysis

K. Wakai, K. Iseki, S. Nishi, 2013, Clinical and Experimental Nephrology.

Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet

T. Fujii, M. Hori, Y. Akagi, 2003, Journal of Clinical & Experimental Nephrology.

Effect of low protein diet and surplus of essential amino acids on the serum concentration and the urinary excretion of methylguanidine and guanidinosuccinic acid in chronic renal failure.

Y. Takamitsu, Y. Tsubakihara, Y. Orita, 1979, Nephron.

Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats.

N. Fujii, T. Ishimoto, T. Nakano, 2014, Journal of the American Society of Nephrology : JASN.

The Most Recent Trends of Peritoneal Dialysis in Japan

K. Iseki, T. Akiba, Y. Tsubakihara, 2008, Peritoneal Dialysis International.

Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: results from a cohort study from the dialysis registry in Japan.

S. Fukuhara, K. Iseki, S. Nakai, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Carpal Tunnel Surgery as Proxy for Dialysis-Related Amyloidosis: Results from the Japanese Society for Dialysis Therapy

K. Iseki, S. Nakai, K. Yamagata, 2014, American Journal of Nephrology.

Efficacy and Safety of Difelikefalin in Japanese Patients With Moderate to Severe Pruritus Receiving Hemodialysis

I. Narita, F. Gejyo, Y. Tsubakihara, 2022, JAMA network open.

The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension

T. Ogihara, Y. Ouchi, K. Kario, 2009, Hypertension Research.

Serum phosphate levels modify the impact of parathyroid hormone levels on renal outcomes in kidney transplant recipients

N. Fujii, N. Ichimaru, N. Nonomura, 2020, Scientific Reports.

Magnesium modifies the association between serum phosphate and the risk of progression to end-stage kidney disease in patients with non-diabetic chronic kidney disease.

H. Rakugi, Y. Isaka, T. Hamano, 2015, Kidney international.

A case of kidney failure and glycosuria.

T. Shoji, Terumasa Hayashi, Y. Tsubakihara, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Quiz Page April 2012

T. Shoji, Terumasa Hayashi, Y. Tsubakihara, 2012 .

Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.

H. Rakugi, Y. Isaka, Y. Nagasawa, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.

N. Fujii, H. Rakugi, N. Ichimaru, 2012, Bone.

Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients

S. Fukuhara, K. Aonuma, S. Morita, 2010, Clinical and Experimental Nephrology.

Tissue and blood cell concentration of methylguanidine in rats and patients with chronic renal failure.

H. Mikami, Y. Tsubakihara, T. Kikuchi, 1981, Nephron.

Effect of arginine or creatinine administration on the urinary excretion of methylguanidine.

Y. Fukuhara, Y. Takamitsu, Y. Tsubakihara, 1978, Nephron.

Vitamin D Receptor Activator Use and Cause-specific Death among dialysis Patients: a Nationwide Cohort Study using Coarsened Exact Matching

K. Wakai, K. Iseki, S. Nakai, 2017, Scientific Reports.

Reverse epidemiology in hemodialysis patients. Lessons from Japanese registries.

S. Nakai, T. Shoji, Y. Nishizawa, 2008, Nephrologie & therapeutique.

Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study.

T. Hasegawa, K. Iseki, S. Nakai, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry

K. Iseki, T. Yokoo, T. Shigematsu, 2015, PLoS ONE.

Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial

N. Yorioka, Y. Ikari, K. Iseki, 2018, JAMA.

Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010.

K. Iseki, S. Nakai, K. Yamagata, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Use of Vitamin D Receptor Activator, Incident Cardiovascular Disease and Death in a Cohort of Hemodialysis Patients

K. Iseki, T. Shigematsu, T. Shoji, 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

2004 Japanese Society for Dialysis Therapy Guidelines for Renal Anemia in Chronic Hemodialysis Patients *

H. Hirakata, T. Akizawa, F. Gejyo, 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Baseline characteristics and anemia treatment for new hemodialysis patients

Y. Ohashi, Y. Tomino, H. Hirakata, 2008 .

Prediction of dialysis patients in Japan : Based on Japanese Society for Dialysis Therapy Registry

K. Wakai, K. Iseki, S. Nakai, 2012 .

Significantly Rapid Relief from Steroid-Resistant Nephrotic Syndrome by LDL Apheresis Compared with Steroid Monotherapy

N. Ueda, E. Imai, K. Hatta, 2001, Nephron.

Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome

N. Ueda, E. Imai, K. Hatta, 1999 .

Effects of Serum Calcium, Phosphorous, and Intact Parathyroid Hormone Levels on Survival in Chronic Hemodialysis Patients in Japan

K. Iseki, S. Nakai, T. Akiba, 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan.

K. Iseki, T. Yokoo, T. Shigematsu, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study

K. Iseki, N. Fujii, H. Rakugi, 2014, PloS one.

Institutional factors influencing regional differences in the 1‐year survival of dialysis patients

K. Wakai, K. Iseki, S. Nishi, 2015, Hemodialysis international. International Symposium on Home Hemodialysis.

ROS and PDGF-beta [corrected] receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration.

Y. Hirose, H. Miyazaki, Y. Tsubakihara, 2009, American journal of physiology. Cell physiology.

Interleukin-8 in chronic renal failure and dialysis patients.

M. Namiki, Y. Tsubakihara, N. Okada, 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients.

T. Miyazaki, T. Niwa, S. Tsukushi, 1997, Mineral and electrolyte metabolism.

Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.

M. Togawa, E. Imai, T. Shoji, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Deoxyspergualin, an immunosuppressant, in patients suffering from nephropathies with crescent formation: an open-label trial to evaluate safety and efficacy

M. Nose, A. Yamauchi, Masaki Kobayashi, 2006, Clinical and Experimental Nephrology.

Bacteriological Qualities of Dialysis Fluid in Japan as of 31 December 2006

K. Iseki, T. Akiba, Y. Tsubakihara, 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Accumulation of indoxyl-beta-D-glucuronide in uremic serum: suppression of its production by oral sorbent and efficient removal by hemodialysis.

T. Miyazaki, K. Maeda, T. Niwa, 1996, Nephron.

Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype.

H. Rakugi, Y. Isaka, R. St-Arnaud, 2015, Kidney international.

Clinical evaluation of peritoneal dialysis with glycerol dialysatec

S. Yuasa, Y. Tsubakihara, I. Nakanishi, 1981 .

[Dietary recommendations for chronic kidney disease, 2007].

M. Hattori, T. Nakao, Y. Tsubakihara, 2007, Nihon Jinzo Gakkai shi.

Elimination mechanisms of ioxaglate, an ionic, low-osmolality radiocontrast agent by hemodialysis

T. Shoji, Terumasa Hayashi, Y. Tsubakihara, 1994 .

Risk factors for peritonitis in continuous ambulatory peritoneal dialysis. Multicenter study.

Y. Tsubakihara, 1990 .

Retention of fetuin-A in renal tubular lumen protects the kidney from nephrocalcinosis in rats.

N. Fujii, H. Kimura-Suda, H. Rakugi, 2013, American journal of physiology. Renal physiology.

Remarkable hyperaldosteronemia in long-term hemodialysis

E. Yamato, Y. Tsubakihara, N. Okada, 1987 .

High prevalence of Helicobacter pylori infection in Japanese patients with membranous nephropathy

E. Imai, Y. Tsubakihara, T. Kaneko, 2006 .

Histochemical and immunoelectron microscopic analysis of ganglioside GM3 in human kidney

H. Rakugi, Y. Isaka, H. Kawakami, 2015, Clinical and Experimental Nephrology.

Identification and characterization of membrane cofactor protein (CD46) in the human kidneys

T. Seya, M. Matsumoto, Terumasa Hayashi, 1994, European journal of immunology.

Effects of low-dose simvastatin therapy on serum lipid levels in patients with moderate hypercholesterolemia: a 12-month study. The Simvastatin Study Group.

H. Fusamoto, M. Hori, M. Matsumoto, 1997, Clinical therapeutics.

Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients.

E. Imai, T. Shoji, Yoshiharu Tsubakihara, 2004, Kidney international.

Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version

Hirokazu Okada, Kazuo Awai, Isao Kubota, 2013, Clinical and Experimental Nephrology.

Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version

Hirokazu Okada, Kazuo Awai, Isao Kubota, 2013, Japanese Journal of Radiology.

Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism.

Masafumi Fukagawa, K. Iseki, M. Fukagawa, 2015, Kidney international.

Japanese society for dialysis therapy renal data registry—a window through which we can view the details of Japanese dialysis population

Norio Hanafusa, K. Iseki, S. Nakai, 2015, Kidney international supplements.

2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

M. Nangaku, S. Morita, H. Hirakata, 2017, Renal Replacement Therapy.

Effects of L-Threo-3,4-Dihydroxyphenylserine on Orthostatic Hypotension in Hemodialysis Patients

F. Marumo, T. Akiba, T. Akizawa, 2002, American Journal of Nephrology.

Successful treatment of heatstroke with prolonged consciousness disorder and multiple organ failure

Jiyoong Kim, K. Katsurada, T. Shoji, 1995 .

Urine levels of CD46 (membrane cofactor protein) are increased in patients with glomerular diseases.

K. Toyoshima, T. Seya, M. Matsumoto, 2000, Clinical immunology.

Japanese Society for Dialysis Therapy Guidelines for Management of Cardiovascular Diseases in Patients on Chronic Hemodialysis

K. Tabei, K. Shimamoto, K. Kugiyama, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysis.

Y. Kawaguchi, H. Echizen, M. Nakayama, 1998, Clinical nephrology.

The authors reply.

K. Iseki, N. Fujii, H. Rakugi, 2014, Kidney international.

Prevalence of human polyoma virus (BK virus and JC virus) infection in patients with chronic renal disease

M. Horio, E. Imai, T. Moriyama, 2005, Clinical and Experimental Nephrology.

Limiting Iron Supplementation for Anemia in Dialysis Patients—The Basis for Japan’s Conservative Guidelines

Hiroyasu Yamamoto, Y. Tsubakihara, 2011, Seminars in dialysis.

Orally Active Vitamin D for Potential Chemoprevention of Posttransplant Malignancy

N. Fujii, H. Rakugi, N. Ichimaru, 2012, Cancer Prevention Research.

Stage at Diagnosis and Prognosis of Colorectal, Stomach, Lung, Liver, Kidney, and Bladder Cancers in Dialysis Patients: A Multicenter Retrospective Study Using Cancer Registry Data and Administrative Data

I. Miyashiro, Y. Tsubakihara, T. Morishima, 2022, Nephron.

An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)

Takayuki Hamano, Tetsuo Shoji, Hidetomo Nakamoto, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline

N. Fujii, H. Rakugi, S. Mikami, 2013, Kidney international. Supplement.

Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients

K. Iseki, N. Fujii, S. Nakai, 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Treatment of colorectal, stomach, and lung cancer in dialysis patients in Osaka Prefecture

Y. Tsubakihara, T. Morishima, Nanami Kida, 2022, Nihon Toseki Igakkai Zasshi.

Multidetector-row computed tomography is useful to evaluate the therapeutic effects of bisphosphonates in glucocorticoid-induced osteoporosis

N. Fujii, H. Rakugi, S. Mikami, 2014, Journal of Bone and Mineral Metabolism.

Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort study.

Y. Isaka, M. Fukunaga, Y. Nagasawa, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Bacteriological Water Quality in the Central Dialysis Fluid Delivery System from the Survey of the Japanese Society for Dialysis Therapy

K. Iseki, S. Nakai, T. Akiba, 2009, Blood Purification.

Benefits of incorporating urinary protein/creatinine ratio measurement in a school urine screening system: The experience of restructuring the school urinary screening system in Osaka Prefecture, Japan

T. Shoji, Terumasa Hayashi, Y. Tsubakihara, 2019, Nephrology.

Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients.

M. Namiki, Y. Tsubakihara, A. Moutabarrik, 1995, Clinical Nephrology.

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011)

Takayuki Hamano, Tetsuo Shoji, Hidetomo Nakamoto, 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease: a retrospective cohort study

H. Rakugi, Y. Isaka, M. Fukunaga, 2013, Clinical and Experimental Nephrology.

A case of successful renal transplantation after CAPD for eleven years with congestive heart failure

T. Shoji, Y. Tsubakihara, N. Okada, 2012 .

Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker

S. Mikami, E. Imai, Y. Nagasawa, 2008, Hypertension Research.

A case of Becker muscular dystrophy and massive myoglobinuria with minimal renal manifestations.

M. Togawa, T. Shoji, Y. Tsubakihara, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Correcting anemia and native vitamin D supplementation in kidney transplant recipients: a multicenter, 2 × 2 factorial, open‐label, randomized clinical trial

Y. Ubara, K. Masutani, Katsunori Yoshida, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial.

M. Nangaku, I. Narita, S. Morita, 2020, Clinical journal of the American Society of Nephrology : CJASN.

[Crush syndrome].

Y. Tsubakihara, Y Tsubakihara, 1997, Ryoikibetsu shokogun shirizu.

Association of nocturnal hypoxemia with progression of CKD.

H. Rakugi, Y. Isaka, T. Shoji, 2013, Clinical journal of the American Society of Nephrology : CJASN.

High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study.

H. Rakugi, Y. Isaka, T. Shoji, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Increased risk of hip fracture among Japanese hemodialysis patients

K. Iseki, I. Narita, J. Kazama, 2013, Journal of Bone and Mineral Metabolism.

Tachycardia as a predictor of poor survival in chronic haemodialysis patients.

K. Iseki, S. Nakai, K. Yamagata, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)

M. Iwasaki, M. Nangaku, I. Narita, 2017, Clinical and Experimental Nephrology.

Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial)

M. Nangaku, I. Narita, S. Morita, 2016, Clinical and Experimental Nephrology.

A prospective observational study of early intervention with erythropoietin therapy and renal survival in non-dialysis chronic kidney disease patients with anemia: JET-STREAM Study

Y. Ohashi, H. Hirakata, T. Akizawa, 2016, Clinical and Experimental Nephrology.

Impacts of Recombinant Human Erythropoietin Treatment During Predialysis Periods on the Progression of Chronic Kidney Disease in a Large‐Scale Cohort Study (Co‐JET study)

Understanding Measurements of Vitality in Patients with Chronic Kidney Disease: Connecting a Quality-of-Life Scale to Daily Activities

S. Fukuhara, S. Morita, T. Akizawa, 2012, PloS one.

Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study

Y. Umayahara, Y. Isaka, T. Hamano, 2019, Scientific Reports.

Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan

K. Iseki, I. Narita, D. Koya, 2010, Clinical and Experimental Nephrology.

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.

M. Hori, M. Hori, M. Togawa, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Early Mortality Was Highly and Strongly Associated with Functional Status in Incident Japanese Hemodialysis Patients: A Cohort Study of the Large National Dialysis Registry

T. Hasegawa, K. Iseki, Y. Shibagaki, 2016, PloS one.

ROS and PDFG- (cid:1) receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration

H. Miyazaki, Y. Tsubakihara, H. Shimizu, 2009 .

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study

M. Iwasaki, M. Nangaku, I. Narita, 2022, PloS one.

Usefulness of measurement of heart rate variability by holter ECG in hemodialysis patients

N. Matsuura, M. Arai, Y. Hamada, 2017, BMC Nephrology.

Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.

N. Fujii, H. Rakugi, S. Mikami, 2012, Bone.

GUANIDINOACETIC ACID(GAA) IN PATIENTS WITH CHRONIC KIDNEY DISEASE(CKD) AND DIABETES MELLITUS(DM)

T. Shoji, Terumasa Hayashi, Y. Tsubakihara, 2012 .

Effects of low-dose simvastatin therapy on serum lipid levels in patients with moderate hypercholesterolemia: a 12-month study

H. Fusamoto, M. Hori, Yoshio Yamada, 1997 .

Elimination of iohexol, a nonionic, low osmolality radiocontrast agent, by hemodialysis.

Y. Tsubakihara, N. Okada, E. Kitamura, 1990 .

Vitamin D deficiency predicts decline in kidney allograft function: a prospective cohort study.

N. Fujii, H. Rakugi, N. Ichimaru, 2014, The Journal of clinical endocrinology and metabolism.

An autopsy-proven case of myeloperoxidase-antineutrophil cytoplasmic antibody-positive polyarteritis nodosa with acute renal failure and alveolar hemorrhage

T. Shoji, Y. Tsubakihara, T. Kaneko, 2011, Clinical and Experimental Nephrology.

A candidate gene approach to genetic contributors to the development of IgA nephropathy.

Y. Yamasaki, H. Rakugi, Y. Isaka, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Survey of dialysis therapy during the Great East Japan Earthquake Disaster and recommendations for dialysis therapy preparation in case of future disasters

J. Minakuchi, K. Nitta, T. Akizawa, 2016, Renal Replacement Therapy.

Effect of anemia correction on left ventricular hypertrophy in patients with modestly high hemoglobin level and chronic kidney disease .

M. Hiroe, M. Akaishi, T. Akizawa, 2013, Journal of cardiology.

Peritoneal Dialysis Registry With 2012 Survey Report

T. Hasegawa, K. Wakai, K. Iseki, 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Regional Variation in Hip Fracture Incidence Among Japanese Hemodialysis Patients

K. Iseki, I. Narita, J. Kazama, 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Guideline–Practice Gap in the Management of Predialysis Chronic Kidney Disease Mineral Bone Disorder in Japan

N. Fujii, H. Rakugi, S. Mikami, 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Higher hemoglobin levels using darbepoetin alfa and kidney outcomes in advanced chronic kidney disease without diabetes: a prespecified secondary analysis of the PREDICT trial.

M. Nangaku, I. Narita, H. Hirakata, 2023, Clinical and Experimental Nephrology.

Guanidinoacetic Acid (GAA) Deficiency and Supplementation in Rats with Chronic Renal Failure (CRF)

Y. Tsubakihara, I. Nakanishi, Y. Orita, 1985 .

Cyclosporin A mono-therapy in nephrotic syndrome with contra-indication of steroid therapy.

M. Togawa, T. Shoji, Y. Tsubakihara, 1999, Internal medicine.

Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial

S. Mikami, Y. Isaka, T. Hamano, 2020, Scientific Reports.

Factors influencing regional differences in the outcome of dialysis in Japan

K. Wakai, K. Iseki, Y. Tsubakihara, 2011 .

Does hypomagnesemia predict faster progression of nondiabetic chronic kidney disease?

H. Rakugi, Y. Isaka, Y. Tsubakihara, 2014, The American journal of medicine.